成纤维细胞活化蛋白
医学
成纤维细胞
生物标志物
癌症研究
小分子
生物化学
癌症
内科学
化学
体外
作者
Shobhana Raju,Jaya Shukla,Rakesh Kumar
出处
期刊:Pet Clinics
[Elsevier]
日期:2022-07-01
卷期号:17 (3): 453-464
被引量:2
标识
DOI:10.1016/j.cpet.2022.03.005
摘要
The evolution of the fibroblast activation protein inhibitor molecules over the past decade has brought into the forefront a novel theranostic agent that has the potential of matching the workhorse of PET/computed tomography, [fluorine-18] fluoro-2-deoxy-d-glucose (18F-FDG). It is hoped that in the next decade it can act as a complementary tracer to 18F-FDG, in providing phenotypic and biomarker information and also in directing fibroblast activation protein-targeted therapies.
科研通智能强力驱动
Strongly Powered by AbleSci AI